Hey Sirwes,
Great piece of work - persisting in getting that better reply. I try about once a month, and only ever get the same generic- fog off.
It dose fall in line, with what the long- term faithful holders have suspected.
In seeing studies increase dosages, but not disclose updated results, has maintained that faith in the science. Put simply without increased efficacy or tolerability, that simply doesn't occur.
Similarly, despite how critical of Leslie I've been over the past six months- with their lack of updates. To be fair back on November 7th (in her podcast) she went over B-Cell being shelved- not scrapped. She explained prioritizing resources, as they simply had too much going on, with the other three studies requiring attention. Namely the time and capital available, in getting their studies off the ground.
I've often referred to Leslie as being a Game Show Host ( everything must be talked up and bubbly ). I'm going to change that view, to that of a passivist. Whilst in your IMU reply Sirwes- They confirm no adverse findings in any of the studies. However, they dance around time factors. My take is that they don't want to burn their relationship with the FDA. They could have easily come out more than a year ago in consoling investors, in stating they've needed to be over selective with patients. The requirements of patients needing to have failed at least two standard of care treatments before being eligible, must have been a major hurdle. You only get one crack at it !
This would require a confidence, that each patient had enough health to see treatment times out. No doubt limiting intakes, and pushing back trial times before even getting started.
Another positive, (for mine) the investors putting up the $20m in capital (Convertible notes, approved at EGM) in having future share prices determining their holdings, they must have a confidence that the SP will be significantly higher in coming months. To put up that stake, no doubt IMU management have shown something in convincing them, that the SP has seen it's lows.
Sirwes, your post has confirmed what I've already suspected. It's great to hear it from IMU though !
Bring on the next 3-5 months, with all of the announced data coming out of the prioritized 3 major studies !
-GO IMU!
Not Financial Advice - Opinions Only - DYOR!
Expand
(20min delay)